Evidence map›Paper›PMID 39567688›Full record

ArticleNature2025

Human HDAC6 senses valine abundancy to regulate DNA damage.

Jiali Jin, Tong Meng, Yuanyuan Yu, Shuheng Wu, Chen-Chen Jiao, Sihui Song, Ya-Xu Li, Yu Zhang, Yuan-Yuan Zhao, Xinran Li and 15 more

RetractedErratum issued 3 registry-linked trialsAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to 3 registered trials, which are not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07488312 phase1enrolling by invitationnot on this map

A Study on the Safety of Leucine-Restricted Diet in Patients With Gastric Cancer

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2025 to 2026Enrolled37ConditionsGastric CancerArmsLeucine-restricted diet.
NCT07537348 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

A Study on the Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer Patients Treated With Chemotherapy and Immunotherapy

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2026 to 2028Enrolled73ConditionsAdvanced Gastric CancerArmsLucine-restricted diet
NCT07537361 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

A Study on the Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer Patients Treated With Neoadjuvant Chemotherapy and Immunotherapy

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2026 to 2027Enrolled108ConditionsGastric Cancer, Leucine-restricted DietArmsLeucine-restricted diet
3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. HDAC6 orchestrates NK cell maturation and antitumor immunity.Journal for immunotherapy of cancer · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Curcumin in High Doses Reverses the UV-B-InducedPharmaceuticals (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Jiali Jin *Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Tong Meng *Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.ORCID http://orcid.org/0000-0001-6403-1357
Yuanyuan Yu *Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Shuheng Wu *Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Chen-Chen JiaoTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Sihui SongTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Ya-Xu LiTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Yu ZhangTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Yuan-Yuan ZhaoTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Xinran LiTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Zixin WangKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Tongji Hospital affiliated to Tongji University, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Yu-Fan LiuTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Runzhi HuangTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Jieling QinTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Yihua ChenShanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai, China.ORCID http://orcid.org/0000-0003-1733-7980
Hao CaoSchool of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
Xiao TanTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Xin GeTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Cong JiangTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Jianhuang XueKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Tongji Hospital affiliated to Tongji University, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China.ORCID http://orcid.org/0000-0003-0623-2200
Jian YuanDepartment of Biochemistry and Molecular Biology, Tongji University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0002-2801-8849
Dianqing WuDepartment of Pharmacology, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7342-5961
Wei WuKey Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0001-5164-2765
Ci-Zhong JiangKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.ORCID http://orcid.org/0000-0001-5406-2360
Ping WangTongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. wangp@tongji.edu.cn.ORCID http://orcid.org/0000-0001-8477-0528

Funding

National Key Research and Development Program of China
6 · The paper itself

Abstract

As an essential branched amino acid, valine is pivotal for protein synthesis, neurological behaviour, haematopoiesis and leukaemia progression

Indexed as

DioxygenasesDNA-Binding ProteinsDNA DamageHistone Deacetylase 6ValineAnimalsCell Line, TumorCell NucleusDietDNA MethylationFemaleHCT116 CellsHumansMaleMiceMice, Inbred C57BLDioxygenasesDNA-Binding ProteinsHDAC6 protein, humanHistone Deacetylase 6TET2 protein, humanValine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.